These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29081089)

  • 1. Evaluation of the Abuse Potential of Novel Amphetamine Derivatives with Modifications on the Amine (NBNA) and Phenyl (EDA, PMEA, 2-APN) Sites.
    Custodio RJP; Botanas CJ; Yoon SS; Peña JB; Peña IJD; Kim M; Woo T; Seo JW; Jang CG; Kwon YH; Kim NY; Lee YS; Kim HJ; Cheong JH
    Biomol Ther (Seoul); 2017 Nov; 25(6):578-585. PubMed ID: 29081089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel synthetic cathinone, 2-(methylamino)-1-(naphthalen-2-yl) propan-1-one (BMAPN), produced rewarding effects and altered striatal dopamine-related gene expression in mice.
    Botanas CJ; Yoon SS; de la Peña JB; Dela Peña IJ; Kim M; Woo T; Seo JW; Jang CG; Park KT; Lee YH; Lee YS; Kim HJ; Cheong JH
    Behav Brain Res; 2017 Jan; 317():494-501. PubMed ID: 27737791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new synthetic drug 5-(2-aminopropyl)indole (5-IT) induces rewarding effects and increases dopamine D1 receptor and dopamine transporter mRNA levels.
    Botanas CJ; Yoon SS; de la Peña JB; Dela Peña IJ; Kim M; Custodio RJ; Woo T; Seo JW; Jang CG; Yang JS; Yoon YM; Lee YS; Kim HJ; Cheong JH
    Behav Brain Res; 2018 Apr; 341():122-128. PubMed ID: 29288746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The abuse potential of two novel synthetic cathinones with modification on the alpha-carbon position, 2-cyclohexyl-2-(methylamino)-1-phenylethanone (MACHP) and 2-(methylamino)-1-phenyloctan-1-one (MAOP), and their effects on dopaminergic activity.
    Botanas CJ; Yoon SS; de la Peña JB; Dela Peña IJ; Kim M; Woo T; Seo JW; Jang CG; Park KT; Lee YH; Lee YS; Kim HJ; Cheong JH
    Pharmacol Biochem Behav; 2017 Feb; 153():160-167. PubMed ID: 28063946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Abuse Potential of α-Piperidinopropiophenone (PIPP) and α-Piperidinopentiothiophenone (PIVT), Two New Synthetic Cathinones with Piperidine Ring Substituent.
    Botanas CJ; Yoon SS; de la Peña JB; Dela Peña IJ; Kim M; Woo T; Seo JW; Jang CG; Park KT; Lee YH; Lee YS; Kim HJ; Cheong JH
    Biomol Ther (Seoul); 2017 Mar; 25(2):122-129. PubMed ID: 28173643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The new designer drug buphedrone produces rewarding properties via dopamine D1 receptor activation.
    Oh JH; Hwang JY; Hong SI; Ma SX; Seo JY; Lee SY; Kim HC; Jang CG
    Addict Biol; 2018 Jan; 23(1):69-79. PubMed ID: 27790823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dopamine D1-D2 receptor heteromer exerts a tonic inhibitory effect on the expression of amphetamine-induced locomotor sensitization.
    Shen MY; Perreault ML; Fan T; George SR
    Pharmacol Biochem Behav; 2015 Jan; 128():33-40. PubMed ID: 25444866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas.
    Hiroi N; White NM
    Brain Res; 1991 Jun; 552(1):141-52. PubMed ID: 1833032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleiotrophin overexpression regulates amphetamine-induced reward and striatal dopaminergic denervation without changing the expression of dopamine D1 and D2 receptors: Implications for neuroinflammation.
    Vicente-Rodríguez M; Rojo Gonzalez L; Gramage E; Fernández-Calle R; Chen Y; Pérez-García C; Ferrer-Alcón M; Uribarri M; Bailey A; Herradón G
    Eur Neuropsychopharmacol; 2016 Nov; 26(11):1794-1805. PubMed ID: 27642078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dual orexin receptor antagonist almorexant, alone and in combination with morphine, cocaine and amphetamine, on conditioned place preference and locomotor sensitization in the rat.
    Steiner MA; Lecourt H; Jenck F
    Int J Neuropsychopharmacol; 2013 Mar; 16(2):417-32. PubMed ID: 22436395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four Novel Synthetic Tryptamine Analogs Induce Head-Twitch Responses and Increase 5-HTR2a in the Prefrontal Cortex in Mice.
    Abiero A; Ryu IS; Botanas CJ; Custodio RJP; Sayson LV; Kim M; Lee HJ; Kim HJ; Seo JW; Cho MC; Lee KW; Yoo SY; Jang CG; Lee YS; Cheong JH
    Biomol Ther (Seoul); 2020 Jan; 28(1):83-91. PubMed ID: 31230432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
    Shuto T; Seeman P; Kuroiwa M; Nishi A
    Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of aprepitant, a clinically used neurokinin-1 receptor antagonist on the expression of conditioned psychostimulant versus opioid reward.
    Mannangatti P; Sundaramurthy S; Ramamoorthy S; Jayanthi LD
    Psychopharmacology (Berl); 2017 Feb; 234(4):695-705. PubMed ID: 28013351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors.
    Houchi H; Babovic D; Pierrefiche O; Ledent C; Daoust M; Naassila M
    Neuropsychopharmacology; 2005 Feb; 30(2):339-49. PubMed ID: 15383833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single exposure to restraint stress induces behavioral and neurochemical sensitization to stimulating effects of amphetamine: involvement of NMDA receptors.
    Pacchioni AM; Gioino G; Assis A; Cancela LM
    Ann N Y Acad Sci; 2002 Jun; 965():233-46. PubMed ID: 12105099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated amphetamine administration and long-term effects on 50-kHz ultrasonic vocalizations: possible relevance to the motivational and dopamine-stimulating properties of the drug.
    Simola N; Morelli M
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):343-55. PubMed ID: 25638025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of D1 and D2 dopamine receptor antagonists on acute amphetamine- or methamphetamine-induced up-regulation of zif/268 mRNA expression in rat forebrain.
    Wang JQ; McGinty JF
    J Neurochem; 1995 Dec; 65(6):2706-15. PubMed ID: 7595569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of d-govadine on conditioned place preference with d-amphetamine or food reward.
    Nesbit MO; Dias C; Phillips AG
    Behav Brain Res; 2017 Mar; 321():223-231. PubMed ID: 28062254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic mechanisms mediating the long-term expression of locomotor sensitization following pre-exposure to morphine or amphetamine.
    Vanderschuren LJ; Schoffelmeer AN; Mulder AH; De Vries TJ
    Psychopharmacology (Berl); 1999 Apr; 143(3):244-53. PubMed ID: 10353426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of SCH23390 and spiperone on the expression of conditioned place preference induced by d-amphetamine or cocaine in the rat.
    Liao RM; Chang YH; Wang SH
    Chin J Physiol; 1998 Jun; 41(2):85-92. PubMed ID: 9801838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.